Rifasutenizol |
| Catalog No.GC70893 |
Rifasutenizol (TNP-2198) is a potent and orally bioavailable dual-targeted antibacterial agent.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1001314-13-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Rifasutenizol exhibits potent bactericidal activity against key microaerophilic and anaerobic bacterial pathogens, including Helicobacter pylori, Clostridioides difficile, and Gardnerella vaginalis, including rifamycin-resistant and nitroimidazole-resistant strains[1].
References:
[1]. Ma Z, et al. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. J Med Chem. 2022;65(6):4481-4495.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *